Simple Analgesics (Acetaminophen and Dipyrone) for Pain

What they are

Acetaminophen (paracetamol) and dipyrone (metamizole) are two of the most widely used analgesics in the world for mild to moderate pain and fever. Although they share the position of step 1 of the WHO analgesic ladder, they are not non-steroidal anti-inflammatory drugs (NSAIDs) — a very common confusion in clinical practice. Both act predominantly through central pathways in the nervous system, with little clinically relevant peripheral anti-inflammatory effect.

Acetaminophen is a pure analgesic and antipyretic: it reduces pain and fever, but barely interferes with peripheral inflammation. This distinguishes it from NSAIDs (ibuprofen, diclofenac, naproxen) and guides its choice when the inflammatory component is not the main driver — or when NSAIDs are contraindicated (peptic disease, chronic kidney disease, high cardiovascular risk). Dipyrone, in addition to being an analgesic and antipyretic, has an additional spasmolytic effect on visceral smooth muscle, which explains its historical usefulness in abdominal and biliary colic.

One relevant point of context: dipyrone is widely available and integrated into medical culture in many countries (Brazil, Germany, Spain, Mexico, Russia); in the United States, United Kingdom, Canada, and Australia it has been withdrawn or severely restricted due to concern about agranulocytosis, a rare but serious reaction. This international divergence generates legitimate debate and deserves to be contextualized without alarmism and without minimizing the risk — the balance between benefit (effective analgesia, low cost, good profile compared to NSAIDs) and this rare risk is an open discussion in the literature.

Mechanism of action

Despite decades of clinical use, the mechanism of action of acetaminophen remains partially unclear. The most accepted hypothesis involves central inhibition of cyclooxygenase — predominantly cerebral COX-2, possibly a variant described as COX-3 — combined with modulation of the descending serotonergic pathway and activation of the endocannabinoid system (via the AM404 metabolite, which inhibits anandamide reuptake). These mechanisms converge toward central analgesia, with a modest peripheral anti-inflammatory effect — which sets it apart from NSAIDs.

Dipyrone has a better-characterized mechanism: predominantly central blockade of cyclooxygenase, activation of the endogenous cannabinoid system, and, distinctively, a myorelaxant effect on visceral smooth muscle. This third component — spasmolytic — explains its historical efficacy in renal, biliary, and intestinal colic, where NSAIDs or acetaminophen alone tend to be less effective.

One clinical implication of these mechanisms: because both act centrally and have limited peripheral effect, in conditions with marked tissue inflammatory component (acute tendinopathy, active arthritis), NSAIDs usually perform better — when not contraindicated. In contrast, in chronic musculoskeletal pain without florid inflammatory signs, tension headache, fever, or colic, acetaminophen and dipyrone remain rational first-line options.

Scientific evidence

The evidence on acetaminophen and dipyrone is extensive in volume but heterogeneous in quality and — in some specific scenarios — counterintuitive relative to established clinical perception. An honest reading of the literature requires differentiating by condition, because the same molecule can perform very differently in acute versus chronic pain, or in musculoskeletal versus visceral pain.

For mild-moderate acute pain, the meta-analyses by Moore et al. aggregated dozens of clinical trials in postoperative pain and headache models, demonstrating consistent benefit of acetaminophen versus placebo, with NNT (number needed to treat) for 50% relief around 3-4 in most models. The effect is modest but reproducible — and increases significantly when acetaminophen is combined with an NSAID or weak opioid.

The most important and disruptive finding came from the study by Saragiotto et al. (Cochrane 2016), a systematic review that concluded that acetaminophen was NOT superior to placebo for pain reduction or functional improvement in acute low back pain. This result was replicated in subsequent analyses and prompted the NICE 2016 guideline to remove acetaminophen as a first-line option in acute low back pain. It is a textbook example of how high-quality evidence can correct a long-established clinical practice.

In osteoarthritis, recent meta-analyses (including the one by Leopoldino et al. published in Cochrane) found a small clinical effect of acetaminophen on pain and function — clinically marginal, often below the threshold of clinical relevance. This repositioned acetaminophen as an adjuvant and no longer as a central piece of OA treatment, especially when topical or oral NSAIDs are feasible.

For dipyrone, the evidence is more modest in volume but consistent in specific indications. The meta-analysis by Konijnenbelt-Peters et al. (Pain Pract) on dipyrone in acute postoperative pain showed efficacy comparable to IV morphine in moderate pain, with a better adverse effect profile. In renal colic, clinical trials demonstrate robust efficacy of IV dipyrone, with performance similar or superior to NSAIDs in some studies.

The most debated point in the dipyrone literature is hematological safety. The review by Kötter et al. (PLoS One 2015) analyzed pharmacovigilance studies and estimated incidence of agranulocytosis associated with dipyrone at around 1 case per million exposures — substantially lower than older estimates (which reached 1:30,000 in some reports from the 1970s-80s) and similar to other drugs in common clinical use. Even so, the methodological heterogeneity of the studies and geographic variation in risk keep the debate open in international guidelines.

Indications

Acetaminophen and dipyrone have partially overlapping and partially complementary indication profiles. The choice between one or the other depends on the predominant clinical picture, the patient's comorbidities, individual tolerance and — in specific contexts — availability and cultural/regional preference. The decision rests with the physician who knows the case.

How they are used

In Brazilian outpatient practice, acetaminophen and dipyrone are available in multiple presentations: tablets, oral drops (useful in pediatrics and geriatrics), syrups, suppositories, and — in the hospital setting — ampoules for intravenous use. Onset of action is relatively fast: 30 to 60 minutes for oral formulations, and 15 to 30 minutes for intravenous administration. The typical duration of analgesic effect is 4 to 6 hours, which guides the dose interval.

The therapeutic decision is not only about which molecule to use, but also about duration of use. Use for short periods (days to 1-2 weeks) with frequent reassessment is the safe standard. Continuous prolonged use should only occur with a clear indication (e.g., cancer pain, specific chronic condition), periodic medical follow-up, and checking of liver function (acetaminophen) and complete blood count (dipyrone, especially in prolonged use).

One frequently underestimated point is rational combination: acetaminophen + NSAID (when there is no contraindication to the NSAID) has well-documented additive effect in postoperative pain and may allow lower doses of each component. Acetaminophen + dipyrone is a less studied combination with uncertain additive benefit — rarely justified outside very specific contexts. These combinations are medical decisions, not self-medication.

Medications by generic name

Acetaminophen is among the most widely available medications worldwide, appears on essential medicines lists, is covered by most insurance, has low cost, and has established generic versions. Most acetaminophen presentations are sold over the counter (no prescription required), which coexists with a self-medication culture that warrants clinical attention — primarily because of the risk of overdose from concomitant use of multiple products containing acetaminophen (present in cold remedies and fixed combinations). Dipyrone is approved in many countries but is not available in the US, UK, Canada, or Australia.

Well-known commercial brands coexist with generics of the same quality at a significantly lower price. For acetaminophen, brands such as Tylenol or Panadol are emblematic, but the generic acetaminophen has demonstrated bioequivalence and is a rational option. In countries where dipyrone is approved, fixed combinations (dipyrone + caffeine + isometheptene) are frequently used in headache, but with limited-quality evidence for the additional components — their use should be restricted to specific indications and for a defined time.

An important practical alert: since acetaminophen is present in dozens of over-the-counter products (cold remedies, combinations for menstrual cramps, combinations for muscle pain), it is common for patients to ingest cumulative doses without realizing it, exceeding the daily limit. This is one of the most frequent causes of inadvertent acetaminophen overdose. During history taking, it is always worth asking explicitly about use of "cold medicines" in the previous days before prescribing additional acetaminophen.

Dosing, interactions, and special populations

Older adults. There is a tendency to reduce the maximum daily dose of acetaminophen in frail older adults — in clinical practice it is common to work with a ceiling of up to 3 g/day instead of the theoretical maximum of 4 g/day, especially in patients with low weight, malnutrition, or polypharmacy. Dipyrone in older adults requires caution due to renal accumulation of metabolites and greater susceptibility to hypotension during IV administration. Periodic reassessment of renal function and complete blood count is prudent when use is prolonged.

Hepatic insufficiency. Acetaminophen is contraindicated in advanced liver disease (Child-Pugh B/C, decompensated cirrhosis, severe acute hepatitis) and requires reduced doses with monitoring in mild to moderate liver disease. Dipyrone may require adjustment but has a wider hepatic safety margin; even so, in advanced liver disease, use is also avoided when possible.

Renal insufficiency. Acetaminophen is generally safe in renal insufficiency (it does not have a significant direct nephrotoxic effect like NSAIDs). Dipyrone requires caution — its metabolites accumulate in renal insufficiency, and in advanced-stage chronic kidney disease, prolonged use is discouraged.

Pregnant women. Acetaminophen is the first-line analgesic in pregnancy, with broad evidence of safety when used in therapeutic doses for short periods. Recent observational studies have raised questions about intense and prolonged exposure — the practical recommendation is "the lowest effective dose for the shortest necessary time", with indication and medical follow-up. Dipyrone is avoided particularly in the third trimester, and use in other trimesters lacks safety data as robust as those of acetaminophen.

Children. Pediatric doses are calculated by weight: acetaminophen typically 10-15 mg/kg every 4-6h (respecting the maximum dose); dipyrone 10-25 mg/kg every 6-8h. Both the choice and dose adjustment in pediatrics should be made by the pediatrician, with special attention to children under 3 months, premature infants, or those with comorbidities.

Adverse effects, risks, and contraindications

At therapeutic doses, acetaminophen and dipyrone have a favorable safety profile — high tolerability and rare adverse events in acute use. However, both have specific serious risks that must be recognized by physicians and patients: severe hepatotoxicity in overdose for acetaminophen, and rare but potentially fatal agranulocytosis for dipyrone.

Common adverse effects of acetaminophen at therapeutic dose: are rare. Mild nausea, skin rash in susceptible patients, and small reversible elevations of transaminases in prolonged use. Digestive tolerability is excellent and clearly superior to that of NSAIDs — one of the arguments for preference in patients with a history of gastropathy.

Common adverse effects of dipyrone: hypersensitivity reactions (urticaria, bronchospasm in asthmatics, rarely severe reactions), hypotension during rapid IV infusion (expected and avoided with slow infusion in saline), and — rarely — agranulocytosis already described above. Mild digestive reactions can occur but are less frequent than with NSAIDs.

Relative contraindications of acetaminophen: advanced liver disease (Child-Pugh B/C), active alcoholism, severe malnutrition, concomitant use of hepatic enzyme inducers at unadjusted doses. Of dipyrone: previous history of agranulocytosis or blood dyscrasia, known hypersensitivity to pyrazolones, concomitant use of myelotoxic agents without monitoring, third trimester of pregnancy.

Limitations and what is still not known

Despite the centuries-old use of acetaminophen and decades of dipyrone, the literature has relevant gaps — and several popular concepts do not withstand a critical reading of current evidence. Evidence-based medicine has resized the role of these drugs in specific scenarios, especially in chronic musculoskeletal pain.

Evidence Gaps

Weak evidence in chronic musculoskeletal pain. For chronic low back pain, established osteoarthritis, and other chronic musculoskeletal conditions, the clinical effect of acetaminophen is small and often marginal. It is still not well known which subgroup of chronic patients benefits clinically in a sustained way — current practice has migrated toward symptomatic use for defined periods, integrated with exercise and multimodal treatment, instead of continuous use.

Safety of dipyrone at large scale outside Brazil and Europe. The most robust pharmacovigilance data come from countries where dipyrone is widely used (Germany, Brazil, Spain, Russia). In regions where the medication was withdrawn decades ago, active surveillance is limited, and contemporary risk estimates lack studies with modern methodology and diverse populations. This is an important gap in the international regulatory debate.

Fixed combinations with modest evidence. Products such as Neosaldina (dipyrone + caffeine + isometheptene) have evidence of limited quality for the additional components; their position in practice should be conservative, with specific indication and short use, not as a "routine" analgesic.

Resized role in osteoarthritis. Recent meta-analyses reduced the place of acetaminophen in OA — clinically relevant especially when an NSAID is contraindicated. It is still not known whether there is a clinically identifiable subgroup of responders or whether the modest aggregate effect indeed reflects a small individual effect.

Relationship with medical acupuncture

Simple analgesics and medical acupuncture are complementary, not competing, modalities in pain management. No pharmacological interactions are described in the available literature between acupuncture and acetaminophen or dipyrone, and the combination is acceptable in the multimodal plan. In chronic pain, moderate-quality evidence suggests that, when acupuncture is integrated into treatment, some patients with chronic low back pain, migraine, and fibromyalgia may need a smaller amount of symptomatic medication — decisions to adjust or reduce dose are exclusively medical.

The most useful operational difference in clinical practice is temporal: simple analgesics offer rapid relief (30-60 min) with short duration (4-6h); acupuncture has a slower onset (response usually appears after 3-6 sessions) but with an effect that extends for days to weeks in responders. This makes the two approaches complementary — the simple analgesic covers the acute crisis; acupuncture works on reducing the average frequency and intensity over time.

In clinical practice, medical acupuncture does not replace simple analgesics. In some patients integrated into a multimodal plan, it can contribute to making symptomatic medication necessary at lower frequency — particularly relevant in those who already have limitations for pharmacological use (liver disease, use of anticoagulants, multiple comorbidities). Dose or frequency adjustments remain a decision of the attending physician. See also our article on acupuncture in multimodal treatment for more details on integration.

When to seek medical care

Acetaminophen and dipyrone are useful for short-term symptomatic relief, but do not replace diagnosis. Seeking medical evaluation is indicated whenever pain persists, intensifies, or comes with signs that go beyond the usual picture.